Our state-of-the-art facilities and experienced team of scientists provide a comprehensive range of solutions to support the lead identification and optimization phases of the drug discovery and development process. 

Our biobanking services include the collection, preservation, and distribution of high-quality biological samples, including human and animal tissue, cells, and fluids. These samples are used in high-throughput screening (HTS) assays to identify new drug candidates and optimize their properties for further development. Additionally, we offer cell line expansion and creation of master cell banks (MCB) and working cell banks (WCB) that are essential for HTS. This service allows the production of large numbers of identical cells with consistent genetic and functional characteristics for use in downstream applications such as drug discovery and development. 

We have extensive experience in the collection and preservation of samples from a wide range of sources, including clinical trials, biopsies, and animal models. Our samples are stored under strict conditions to ensure their quality and integrity and are available for distribution to our clients on demand. 

In addition to providing samples, we also offer a range of value-added services to support our clients’ HTS efforts. These include sample preparation and processing, assay development and optimization, and data analysis. Our team of experts work closely with our clients to understand their specific needs and develop tailored solutions to support their drug discovery and development efforts. 

At BIOMEX, we understand the importance of timely and reliable access to high-quality samples in the drug discovery and development process. That’s why we are committed to providing our clients with the highest level of service and support. Whether you’re a pharmaceutical company, biotech, or academic research institution, we have the expertise and resources to support your lead identification and optimization efforts.